NCT07251062 2025-11-26A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.CSPC Megalith Biopharmaceutical Co.,Ltd.Phase 2/3 Not yet recruiting737 enrolled